并非所有抗菌溶液在去除生物膜方面等效:不同骨科表面的比较
该体外研究在钴铬、氧化锆和聚甲基丙烯酸甲酯表面培养耐甲氧西林敏感金黄色葡萄球菌和大肠埃希菌生物膜24及72小时,用不同抗菌溶液处理3分钟。10%聚维酮碘联合过氧化氢在多种表面清除耐甲氧西林敏感金黄色葡萄球菌和大肠埃希菌生物膜,10%聚维酮碘单独使用对72小时耐甲氧西林敏感金黄色葡萄球菌和大肠埃希菌生物膜也有效。作者认为10%聚维酮碘溶液可考虑用于临床。
要点
- 10%聚维酮碘联合过氧化氢在氧化锆和钴铬表面根除所有耐甲氧西林敏感金黄色葡萄球菌生物膜。
- 10%聚维酮碘单独在72小时耐甲氧西林敏感金黄色葡萄球菌生物膜上于氧化锆和钴铬表面根除所有细菌。
- 仅10%聚维酮碘(联合或不联合过氧化氢)对72小时大肠埃希菌生物膜在所有表面达到临床有效。
核心结论
- 不同抗菌溶液对细菌生物膜的杀菌效力差异很大。
- 10%聚维酮碘溶液联合或不联合过氧化氢在多种骨科表面持续清除耐甲氧西林敏感金黄色葡萄球菌和大肠埃希菌生物膜,作者认为可考虑用于临床。
研究设计与样本
- 体外研究,在钴铬、氧化锆和聚甲基丙烯酸甲酯圆片上培养耐甲氧西林敏感金黄色葡萄球菌和大肠埃希菌生物膜24及72小时。
- 生物膜覆盖的圆片用对照或不同抗菌溶液处理3分钟,处理后超声定量黏附细菌或用扫描电镜鉴定生物膜。
- 抗菌溶液包括10%聚维酮碘、10%聚维酮碘与3%过氧化氢1:1混合液、稀释聚维酮碘、0.05%葡萄糖酸氯己定以及含乙醇、乙酸、乙酸钠、苯扎氯铵和水的表面活性剂配方。
- 抗菌溶液若较对照产生3个对数级(1000倍)菌落形成单位减少则被认为有效。
主要发现
- 在氧化锆和钴铬表面,10%聚维酮碘联合过氧化氢根除所有耐甲氧西林敏感金黄色葡萄球菌,并在聚甲基丙烯酸甲酯上对24小时耐甲氧西林敏感金黄色葡萄球菌生物膜(p < 0.0002)和72小时耐甲氧西林敏感金黄色葡萄球菌生物膜(p = 0.002)达到临床有效。
- 对72小时耐甲氧西林敏感金黄色葡萄球菌生物膜,10%聚维酮碘在氧化锆和钴铬表面根除所有细菌,并在聚甲基丙烯酸甲酯上达到临床有效(p = 0.04)。
- 对24小时耐甲氧西林敏感金黄色葡萄球菌生物膜,10%聚维酮碘在所有表面达到有效(所有p < 0.01)。
- 基于表面活性剂的配方仅对钴铬(p = 0.04)和氧化锆(p = 0.07)上的72小时耐甲氧西林敏感金黄色葡萄球菌生物膜达到临床有效。
- 对72小时大肠埃希菌生物膜,10%聚维酮碘联合或不联合过氧化氢在所有表面达到临床有效,无其他溶液对耐甲氧西林敏感金黄色葡萄球菌或大肠埃希菌达到临床有效。
关键数值与推荐
- 抗菌溶液有效定义为较对照产生3个对数级(1000倍)菌落形成单位减少。
临床怎么用
- 作者认为10%聚维酮碘溶液联合或不联合过氧化氢可考虑用于临床。
- 临床医生在治疗耐甲氧西林敏感金黄色葡萄球菌或大肠埃希菌生物膜时,应知晓抗菌溶液在不同骨科表面上的效力差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antiseptic solutions are commonly utilized during total joint arthroplasty (TJA) to prevent and treat periprosthetic joint infection (PJI). The purpose of this study was to investigate which antiseptic solution is most effective against methicillin-sensitive Staphylococcus aureus (MSSA) and Escherichia coli biofilms established in vitro on orthopaedic surfaces commonly utilized in total knee arthroplasty: cobalt-chromium (CC), oxidized zirconium (OxZr), and polymethylmethacrylate (PMMA). METHODS: MSSA and E. coli biofilms were grown on CC, OxZr, and PMMA discs for 24 and 72 hours. Biofilm-coated discs were treated with control or various antiseptic solutions for 3 minutes. Solutions included 10% povidone-iodine, a 1:1 mixture of 10% povidone-iodine plus 3% hydrogen peroxide, diluted povidone-iodine, 0.05% chlorhexidine gluconate, and a surfactant-based formulation of ethanol, acetic acid, sodium acetate, benzalkonium chloride, and water. Following treatment, discs were sonicated to quantify adherent bacteria or underwent imaging with scanning electron microscopy to identify biofilm. Antiseptic solutions were considered efficacious if they produced a 3-log (1,000-fold) reduction in colony-forming units compared with controls. RESULTS: On both OxZr and CC, 10% povidone-iodine with hydrogen peroxide eradicated all MSSA, and it achieved clinical efficacy on PMMA at both 24-hour MSSA biofilm (p < 0.0002) and 72-hour MSSA biofilm (p = 0.002). On 72-hour MSSA biofilm, 10% povidone-iodine eradicated all bacteria on OxZr and CC, and it achieved clinical efficacy on PMMA (p = 0.04). On 24-hour MSSA biofilm, 10% povidone-iodine achieved efficacy on all surfaces (all p < 0.01). The surfactant-based formulation only achieved clinical efficacy on 72-hour MSSA biofilms on CC (p = 0.04) and OxZr (p = 0.07). On 72-hour E. coli biofilm, 10% povidone-iodine with or without hydrogen peroxide achieved clinical efficacy on all surfaces. No other solution achieved clinical efficacy on either MSSA or E. coli. CONCLUSIONS: Antiseptic solutions vary considerably in efficacy against bacterial biofilm. The 10% povidone-iodine solution with or without hydrogen peroxide consistently removed MSSA and E. coli biofilms on multiple orthopaedic surfaces and should be considered for clinical use. CLINICAL RELEVANCE: Clinicians should be aware of the differences in the efficacy of antiseptic solutions on different orthopaedic surfaces when treating MSSA or E. coli biofilms.
引用
- Chao CA, Khilnani TK, Jo S, et al. Not All Antiseptic Solutions Are Equivalent in Removing Biofilm: A Comparison Across Different Orthopaedic Surfaces. J Bone Joint Surg Am. 2024. PMID: 39812721. doi:10.2106/JBJS.23.01118
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。